Prosecution Insights
Last updated: August 06, 2026

Entralta

15 pending office actions • 12 clients • 15 examiners • 15 art units • 0 of 15 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Quality Metrics (n=780 apps, methodology: how we score firms)

82.7%
Allowance Rate
n=780
+0.87σ
Allowance Rate (norm)
n=780
2.7
OAs to Allowance
n=415
-0.66σ
OAs to Allow (norm)
n=415
971 days
Time to Allowance
n=415
+18.3pp
Interview Lift
n=780
17.3%
RCE Rate
n=780
0.7%
Appeal Rate
n=780

Rejection Performance (% of received rejections ultimately overcome)

72.2%
§101 Overcome
n=72
73.7%
§102 Overcome
n=133
75.4%
§103 Overcome
n=280
75.3%
§112 Overcome
n=275

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
37%
Top-3 CPC Share
n=780
0
Practitioners
n=780
Apps / Practitioner
n=780 (min 20)

Portfolio Summary

15
Total Pending OAs
10
Non-Final OAs
4
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (60%)
6
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (13%)
§103 only5 (33%)
Double-patenting + other1 (7%)
Multi-statute (no §101)7 (47%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
60% of docket
0
Information Tech
0% of docket
1
Communications
7% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

150 h
Manual time on pending OAs
30 h
Time saved (low, 20%)
52 h
Time saved (mid, 35%)
1.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRINH, HONG-VAN N 1 62.3% +58.7%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
DOUGHERTY, SEAN PATRICK 1 74.9% +15.1%
NGUYEN, SON T 1 28.8% +16.5%
ROTONDI, CONNOR JON 1
WHITTINGTON, JESS G 1 72.9% +17.7%
PRIEST, JESSICA MARIE 1
SWIFT, CANDICE LEE 1 57.0% +36.3%
HAILE, BENYAM 1 62.0% +24.2%
WELLES, COLMAN THOMAS 1 25.0% +49.0%

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18589334 DEVICE AND SOFTWARE APPLICATION FOR DETECTING BLOOD ALCOHOL CONTENT DOUGHERTY, SEAN PATRICK 31d overdue
17767859 ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF DABKOWSKI, ERINNE R 2d overdue
18306099 FORMULATIONS CONTAINING ERYTHRITOL AND COMBINATION SKIN THERAPIES WELLES, COLMAN THOMAS 5d
18563348 IMMUNOMODULATION OF TUMOR MICROENVIRONMENT PRIEST, JESSICA MARIE 12d
19197886 MICRONEEDLE DEVICE FOR INTRAOCULAR INJECTIONS AND METHODS OF USING THE SAME TRINH, HONG-VAN N 23d
18858722 FORMULATION FOR TREATING URINARY SYSTEM DISORDERS SCOTLAND, REBECCA LYNN
18581367 HIGH EFFICIENCY PLANTER SYSTEM AND METHOD NGUYEN, SON T
18442273 PASSIVE AEROBIC TREATMENT UNIT AND METHOD OF USE ROTONDI, CONNOR JON

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18589334 DEVICE AND SOFTWARE APPLICATION FOR DETECTING BLOOD ALCOHOL CONTENT DOUGHERTY, SEAN PATRICK 31d overdue
18273760 SYSTEM AND METHOD FOR USING A WEARABLE DEVICE WITH BIOFEEDBACK SENSORS TO MITIGATE DISEASE TRANSMISSION HAILE, BENYAM 24d overdue
18306099 FORMULATIONS CONTAINING ERYTHRITOL AND COMBINATION SKIN THERAPIES WELLES, COLMAN THOMAS 5d
19197886 MICRONEEDLE DEVICE FOR INTRAOCULAR INJECTIONS AND METHODS OF USING THE SAME TRINH, HONG-VAN N 23d
18581367 HIGH EFFICIENCY PLANTER SYSTEM AND METHOD NGUYEN, SON T
18407211 MOBILE TRANSPORT SYSTEM AND METHOD FOR DELIVERING ITEMS AND SERVICES WHITTINGTON, JESS G
18285641 BIOACTIVE PRODUCTS SWIFT, CANDICE LEE

Client Portfolio (12 clients)

Top Art Units

Art UnitApps
37831
16151
37911
36431
17791
36661
16421
16571
26881
16121

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19197886 MICRONEEDLE DEVICE FOR INTRAOCULAR INJECTIONS AND METHODS OF USING THE SAME Oculogenex Inc. TRINH, HONG-VAN N 3783 §102§103§112 Non-Final OA 23d Pending May 02, 2025
18858722 FORMULATION FOR TREATING URINARY SYSTEM DISORDERS Watershed Medical, Inc. SCOTLAND, REBECCA LYNN 1615 §103 Non-Final OA Pending Oct 21, 2024
18589334 DEVICE AND SOFTWARE APPLICATION FOR DETECTING BLOOD ALCOHOL CONTENT Tracklet Inc. DOUGHERTY, SEAN PATRICK 3791 §101§102§103§112 Non-Final OA 31d overdue Pending Feb 27, 2024
18581367 HIGH EFFICIENCY PLANTER SYSTEM AND METHOD Meb Holdings LLC NGUYEN, SON T 3643 §102§103 Non-Final OA Pending Feb 19, 2024
18442273 PASSIVE AEROBIC TREATMENT UNIT AND METHOD OF USE Waihome LLC ROTONDI, CONNOR JON 1779 §102§103§112 Non-Final OA Pending Feb 15, 2024
18407211 MOBILE TRANSPORT SYSTEM AND METHOD FOR DELIVERING ITEMS AND SERVICES Bib Technologies, Inc. WHITTINGTON, JESS G 3666 §103Other Final Rejection Pending Jan 08, 2024
18563348 IMMUNOMODULATION OF TUMOR MICROENVIRONMENT Cls Therapeutics Limited PRIEST, JESSICA MARIE 1642 §102§103§112Other Non-Final OA 12d Pending Nov 21, 2023
18285641 BIOACTIVE PRODUCTS Victor Tets SWIFT, CANDICE LEE 1657 §102§103§112DP Non-Final OA Pending Oct 04, 2023
18273760 SYSTEM AND METHOD FOR USING A WEARABLE DEVICE WITH BIOFEEDBACK SENSORS TO MITIGATE DISEASE TRANSMISSION Tracklet Inc. HAILE, BENYAM 2688 §103Other Non-Final OA 24d overdue Pending Jul 21, 2023
18306099 FORMULATIONS CONTAINING ERYTHRITOL AND COMBINATION SKIN THERAPIES Innomed Technologies, Inc. WELLES, COLMAN THOMAS 1612 §103Other Final Rejection 5d Pending Apr 24, 2023
18030996 NANOPARTICLE FOR ANTI-CANCER PEPTIDES AND USES THEREOF King'S College London KONOPELSKI SNAVEL, SARA ELIZABETH 1658 §103§112Other Non-Final OA Pending Apr 08, 2023
17767859 ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF King'S College London DABKOWSKI, ERINNE R 1654 §103§112Other Non-Final OA 2d overdue Pending Apr 08, 2022
17626616 TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITY Cls Therapeutics Limited WEN, SHARON X 1641 §103Other Final Rejection 9d Pending Jan 12, 2022
17472370 DETECTABLE ARRAYS, SYSTEMS FOR DIAGNOSIS, AND METHODS OF MAKING AND USING THE SAME Entopsis, Inc. BUNKER, AMY M 1684 §101§112 Final Rejection Pending Sep 10, 2021
16333914 HEART CANNULA Sun Medical Technology Research GHAND, JENNIFER LEIGH-STEWAR 3796 §103§112 Non-Final OA Pending Mar 15, 2019

Managing Entralta's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month